Clinical trial
Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in…
NCT00417729 · Taichung Veterans General Hospital, Other · Completed
Key facts
| NCT number | NCT00417729 |
|---|---|
| Title | Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DM |
| Official title | Phase 4 Study Evaluation of the Effects of Acarbose Versus Glibenclamide on Mean Amplitude of Glycemic Excursions and Oxidative Stress in Patients With Type 2 Diabetes Insufficiently Controlled by Metformin |
| Lead sponsor | Taichung Veterans General Hospital, Other |
| Collaborators | Taipei Veterans General Hospital, Taiwan Changhua Christian Hospital |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Acarbose |
| Enrollment | 51 |
| Start date | Jan 1, 2007 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jan 4, 2007 |
| Last update posted | May 12, 2010 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: